HSBC Holdings’s Edwards Lifesciences EW Stock Holding History

HSBC Holdings’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,100	Closed	-$452K	–	3110
2024 Q4	$452K	Hold	6,100	–	–	﹤0.01%	2247
2024 Q3	$401K	Hold	6,100	–	–	﹤0.01%	2134
2024 Q2	$569K	Buy	+6,100	New	+$540K	﹤0.01%	1912
2021 Q2	–	Sell	-20,700	Closed	-$1.73M	–	2966
2021 Q1	$1.73M	Sell	20,700 -6,700	-24%	-$566K	﹤0.01%	1359
2020 Q4	$2.48M	Buy	27,400 +8,800	+47%	+$730K	﹤0.01%	1261
2020 Q3	$1.5M	Buy	+18,600	New	+$1.45M	﹤0.01%	1379
2020 Q1	–	Sell	-138,600	Closed	-$10.7M	–	2790
2019 Q4	$10.7M	Hold	138,600	–	–	0.02%	795
2019 Q3	$10.2M	Buy	138,600 +98,100	+242%	+$6.89M	0.02%	851
2019 Q2	$2.49M	Buy	+40,500	New	+$2.45M	﹤0.01%	1440
2019 Q1	–	Sell	-62,700	Closed	-$3.2M	–	2755
2018 Q4	$3.2M	Hold	62,700	–	–	0.01%	1296
2018 Q3	$3.64M	Hold	62,700	–	–	0.01%	1254
2018 Q2	$3.04M	Buy	+62,700	New	+$2.93M	0.01%	1342

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

HSBC Holdings's EW Position: Q1 2026 in Review

HSBC Holdings reduced its Edwards Lifesciences (EW) stake by 18% in Q1 2026, selling an estimated $31.2M and leaving 1,770,962 shares worth $142M. The position accounts for 0.07% of the portfolio, ranked #255.

HSBC Holdings first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $183M in Q4 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

HSBC Holdings held 1,770,962 shares of Edwards Lifesciences worth $142M as of Q1 2026.
HSBC Holdings sold 378,012 Edwards Lifesciences shares in Q1 2026, an estimated $31.2M.
Edwards Lifesciences made up 0.07% of HSBC Holdings's portfolio in Q1 2026, its #255 holding.
HSBC Holdings first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
HSBC Holdings's Edwards Lifesciences position peaked at $183M in Q4 2025.
1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.